AKBA
Akebia Therapeut (AKBA)
NASDAQ
$1.33+$0.005 (+0.38%)
Price as of Aug 03, 2026 8:58 AM EDT
  • $354.1M
    Market Cap
  • -64.52%
    1-Year Change
  • Drug Manufacturers - Specialty & Generic
    Industry
AKBA
vs History
vs S&P 500
General Statistics
Latest Close
$1.32
Change
-$0.03 (-2.22%)
Open
$1.34
High
$1.35
Low
$1.29
Previous Close
$1.35
Volume
2,057,838
30-Day Average Volume
3,264,133
1-Week Change
8.20%
1-Month Change
15.79%
1-Year Change
-64.52%
3-Year Change
-20.96%
5-Year Change
-46.56%
Fundamentals
Shares Outstanding
268.3M
Total Assets
$362.5M
Market Cap
$354.1M
Enterprise Value
$240.3M
Period:
QTR
TTM
FY
Revenue
$0.00
Net Income
-$9.1M
Free Cash Flow
-$21.3M
EBIT
-$4.2M
EBITDA
-$3.9M
Net Working Capital
$69.6M
EPS
-$0.03
Enterprise Value/EBITDA
-61
Enterprise Value/Revenue
N/A
P/B
13
P/E
-44
PEG
-1
Price/Free Cash Flow
-17
Price/Operating Cash Flow
-17
Dividends & Splits
Forward Annual Dividend Yield
N/A
Trailing Annual Dividend Yield
N/A
Ex-Dividend Date
N/A
Last Split Factor
N/A
Last Split Date
N/A

Earnings & Revenue